跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Vertikind-16
Approved
STANDARD
Vertikind-16
Windlas Biotech Private Limited (Plant-1)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5333634feafcc141
Company
Windlas Biotech Private Limited (Plant-1)
Type
Standard
Approval Details
Approval Id
5333634feafcc141
Drug Approval Philippines Name
Vertikind-16
Product Name
Vertikind-16
Registration Number
DRP-5645
Brand Name
Vertikind-16
Generic Name
Betahistine Hydrochloride
Dosage Form
Tablet
Dosage Strength
16 mg
Manufacturer
Windlas Biotech Private Limited (Plant-1)
Trader
Mankind Pharma Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
29 November 2024
Expiry Date
27 November 2030
Pharmacologic Category
Antivertigo
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5333634feafcc141
Type
Standard
Back to Philippines FDA Approvals
Vertikind-16 - Philippines FDA Drug Approval Details